NORTHSTRIVE FUND II LP - 10 Feb 2026 SCHEDULE 13G Report for enVVeno Medical Corp Common Stock, $0.00001 par value per share

Filing Manager
NORTHSTRIVE FUND II LP
Reporting Manager
Braeden Lichti
Security
enVVeno Medical Corp Common Stock, $0.00001 par value per share
Shares outstanding
656,455 shares
Disclosed Ownership
33,151 shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 16:29:24 UTC
Date of event
10 Feb 2026
Next filing
20 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"NORTHSTRIVE FUND II LP disclosed 5% ownership in enVVeno Medical Corp Common Stock, $0.00001 par value per share on 10 Feb 2026."

Quick Takeaways

  • NORTHSTRIVE FUND II LP filed SCHEDULE 13G for enVVeno Medical Corp Common Stock, $0.00001 par value per share.
  • Disclosed ownership: 5%.
  • Date of event: 10 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Feb 2026, 16:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Northstrive Fund II LP 3.1% 20,129 0 20,129 /s/ Braeden Lichti Braeden Lichti, Manager
Braeden Lichti 5% 33,151 13,022 20,129 /s/ Braeden Lichti Braeden Lichti

Sponsored